KCNJ11 and type 2 diabetes mellitus: A study conducted in two independent cohorts of Chinese T2D patients (cohort 1: n = 661, cohort 2: n = 607) treated with gliclazide demonstrated that KCNJ11 rs5210 was positively associated with gliclazide response in cohort 1 study [46].